Publications by authors named "John Ginis"

Claim this Profile
S
Safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine coadministered with quadrivalent influenza vaccine: A phase 3 randomized trial.
Kevin Cannon, Jose F Cardona, Kari Yacisin, Allison Thompson, Todd J Belanger, John Ginis

Vaccine· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years.
Patricia Winokur, Juleen Gayed, David Fitz-Patrick, Stephen J Thomas, Oyeniyi Diya, John Ginis

N Engl J Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age.
Donald Hurley, Carl Griffin, Mariano Young, Daniel A Scott, Michael W Pride, John Ginis

Clin Infect Dis· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MenB-FHbp Vaccine Protects Against Diverse Meningococcal Strains in Adolescents and Young Adults: Post Hoc Analysis of Two Phase 3 Studies.
Johannes Beeslaar, Judith Absalon, Annaliesa S Anderson, Joseph J Eiden, Paul Balmer, John Ginis

Infect Dis Ther· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults.
Allison Thompson, Erik Lamberth, Joseph Severs, Ingrid Scully, Sanela Tarabar, John Ginis

Vaccine· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults.
Lars Ostergaard, Timo Vesikari, Judith Absalon, Johannes Beeslaar, Brian J Ward, John Ginis

N Engl J Med· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity, Tolerability and Safety in Adolescents of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered with Quadrivalent Human Papilloma Virus Vaccine.
Shelly Senders, Prakash Bhuyan, Qin Jiang, Judith Absalon, Joseph J Eiden, John Ginis

Pediatr Infect Dis J· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity, safety, and tolerability of the meningococcal serogroup B bivalent rLP2086 vaccine in adult laboratory workers.
David M Reiner, Prakash Bhuyan, Joseph J Eiden, John Ginis, Shannon Harris

Vaccine· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis